A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

NCT07675590 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Adult Subjects
Obesity & Overweight

Interventions

DRUG: TIX100
DRUG: Placebo

Sponsor

TIXiMED, Inc.